← Leaderboards
Enrico M Novelli
University Of Pittsburgh At Pittsburgh
$7,361,375
Attributed
$10,130,575
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,130,575 · 8
By mechanism
R01$7,063,110 · 3
R44$1,017,232 · 1
T32$981,967 · 1
K23$728,784 · 1
R21$262,988 · 1
R25$76,494 · 1
Top collaborators
- Carolyn J Anderson4 shared
- Biree Andemariam1 shared
- Melissa C Caughey1 shared
- Matthew S Karafin1 shared
- Matthew D Neal1 shared
- Laurel Omert1 shared
- Melanie J. Scott1 shared
- Anirban Sen Gupta1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Solomon Fiifi Ofori-Acquah$18,588,176
- Bartley Perry Griffith$16,952,709
- Deirdre Nolfi-Donegan$513,184
- Rimi Hazra$429,580
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaClinical ResearchPreventBlood VesselsTransgenic OrganismsGrantOxidative StressMediatingMultidisciplinaryLinkSickle CellInflammatoryResponseAdultHemoglobinUniversitiesHemolysisBloodFunctional DisorderAffectCohortProgramsErythrocytesHematology
Grant awards (25)
Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia$1,017,232
R44 · FY2025 · HL
PET Imaging of Vaso-Occlussive Crisis in Sickle Cell Disease$554,636
R01 · FY2025 · HL · contact PI
Chronic dehydration in sickle cell disease: An actionable biomarker to prevent vaso-occlusive episodes$131,050
R21 · FY2025 · HL
PET Imaging of Vaso-Occlussive Crisis in Sickle Cell Disease$694,482
R01 · FY2024 · HL · contact PI
Chronic dehydration in sickle cell disease: An actionable biomarker to prevent vaso-occlusive episodes?$131,938
R21 · FY2024 · HL
Multidisciplinary Research Training in Hematology$98,387
T32 · FY2024 · HL · contact PI
PET Imaging of Vaso-Occlussive Crisis in Sickle Cell Disease$666,750
R01 · FY2023 · HL · contact PI
Multidisciplinary Research Training in Hematology$301,947
T32 · FY2023 · HL · contact PI
Mechanisms of platelet exosome-mediated acute chest syndrome in sickle cell disease$775,062
R01 · FY2022 · HL · contact PI
PET Imaging of Vaso-Occlussive Crisis in Sickle Cell Disease$763,136
R01 · FY2022 · HL · contact PI
Multidisciplinary Research Training in Hematology$299,712
T32 · FY2022 · HL · contact PI
Multidisciplinary Research Training in Hematology$189,559
T32 · FY2021 · HL · contact PI
Neurovascular Determinants of Cognitive Function in Adults with Sickle Cell Disease$688,814
R01 · FY2020 · HL · contact PI
Multidisciplinary Research Training in Hematology$92,362
T32 · FY2020 · HL · contact PI
Neurovascular Determinants of Cognitive Function in Adults with Sickle Cell Disease$702,667
R01 · FY2019 · HL · contact PI
Pittsburgh Intensive Training in Hematology Research$76,494
R25 · FY2019 · HL · contact PI
Neurovascular Determinants of Cognitive Function in Adults with Sickle Cell Disease$717,842
R01 · FY2018 · HL · contact PI
Neurovascular Determinants of Cognitive Function in Adults with Sickle Cell Disease$11,526
R01 · FY2018 · HL · contact PI
Neurovascular Determinants of Cognitive Function in Adults with Sickle Cell Disease$736,583
R01 · FY2017 · HL · contact PI
Platelet TSP1 Mediates Vascular Disease and pulmonary hypertension in Sickle Cell$166,104
K23 · FY2017 · HL · contact PI
Neurovascular Determinants of Cognitive Function in Adults with Sickle Cell Disease$751,612
R01 · FY2016 · HL · contact PI
Platelet TSP1 Mediates Vascular Disease and pulmonary hypertension in Sickle Cell$166,104
K23 · FY2016 · HL · contact PI
Platelet TSP1 Mediates Vascular Disease and pulmonary hypertension in Sickle Cell$132,192
K23 · FY2015 · HL · contact PI
Platelet TSP1 Mediates Vascular Disease and pulmonary hypertension in Sickle Cell$132,192
K23 · FY2014 · HL · contact PI
Platelet TSP1 Mediates Vascular Disease and pulmonary hypertension in Sickle Cell$132,192
K23 · FY2013 · HL · contact PI